Reviewing signature performance across pan-cancer samples, we showed that the Zhang CD8 TCS signature had the overall closest correlation with patient OS and PFI.16 Survival curves for both OS and PFI demonstrated statistically significant prolonged OS and PFI in TCGA samples demonstrating higher concordance with this Zhang CD8 TCS score (Fig. 2). This evidence concerns the gene CD8A and cancer.